Jon Burrows
- Molecular Biology
- Hepatology top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- James G. ChristensenRavi SalgiaXueyan WangLany RuslimRandall SchreckJohn RamphalJulie M. CherringtonSteven Do
- Topics
- Monoclonal and Polyclonal Antibodies Research (9 papers)HER2/EGFR in Cancer Research (5 papers)Advanced Biosensing Techniques and Applications (4 papers)
- Cited by
- HepatologyOncologyMolecular Biology
- Partner nations
- United StatesSpainSouth Korea
In The Last Decade
Jon Burrows
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 674
- Hepatology 503
- Oncology 429
- Pulmonary and Respiratory Medicine 238
- Pathology and Forensic Medicine 154
Countries citing papers authored by Jon Burrows
This map shows the geographic impact of Jon Burrows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Burrows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Burrows more than expected).
Fields of papers citing papers by Jon Burrows
This network shows the impact of papers produced by Jon Burrows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Burrows. The network helps show where Jon Burrows may publish in the future.
Co-authorship network of co-authors of Jon Burrows
This figure shows the co-authorship network connecting the top 25 collaborators of Jon Burrows. A scholar is included among the top collaborators of Jon Burrows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Burrows. Jon Burrows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 32 | |
| 3 | 68 | |
| 4 | 31 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 40 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 6 | |
| 14 | 48 | |
| 15 | 1 | |
| 16 | 50 | |
| 17 | 3 | |
| 18 | 5 | |
| 19 | 424 | |
| 20 | A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. | 421 |
About Jon Burrows
Jon Burrows is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Oncology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Biosensing Techniques and Applications (4 papers). The work is most often cited by research in Hepatology (503 citations), Oncology (429 citations) and Molecular Biology (674 citations). Jon Burrows has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include James G. Christensen, Ravi Salgia, Xueyan Wang, Lany Ruslim, Randall Schreck, John Ramphal, Julie M. Cherrington, Steven Do, Phuong Le and Robert A. Blake. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.